Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

ASX Cannabis Stocks in 2026: Is the risk worth the reward?

It has been a while since we've looked at ASX Cannabis Stocks, and we are sure we are not the only ones to have paid little attention to it. Nonetheless, there were times when we paid closer attention - who could forget late 2020 when the TGA declassified low-dose CBD products, allowing them to be…

ByNick SundichMarch 5, 2026

Shape Australia Corporation (ASX:SHA): On track for >$1bn revenue this year even in a tough construction market

How has a late 2021 IPO focused on commercial fit outs - as Shape Australia Corporation (ASX:SHA) was and is; managed to find itself <3x higher than its IPO price? It went through one of the toughest times to be in the construction space in living memory, even companies such as Reliance Worldwide (ASX:RWC) with…

ByNick SundichFebruary 26, 2026

Sports Entertainment Group (ASX: SEG) Doubles EBITDA and Upgrades Guidance – Is This Small Cap a Buy?

Sports Entertainment doubles EBITDA and lifts guidance Sports Entertainment Group (ASX: SEG) was in serious trouble two years ago. In late 2023, it needed emergency funding just to stay afloat. Now, the picture looks very different. This week, SEG reported the strongest half-year result in its history. EBITDA almost doubled to A$9.7 million, revenue rose…

ByUjjwal MaheshwariFebruary 19, 2026

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

In all our years, we have seen our fair share of ASX Company Spin. It is repeated because often investors fall for it. Even if not all do, it is sufficient that some investors fall for it to achieve what has to be achieved. For instance, that enough believe a capital raising at a >25% discount…

ByNick SundichFebruary 19, 2026

Why Investors Are Rotating Into ASX Small Caps- 5 Top Picks for 2026

ASX Small Caps Are Back on the Radar for 2026 An interesting development occurred on the ASX in 2025. While most investors focused on big, well-known stocks, ASX small-cap shares quietly performed much better. The Small Ordinaries Index rose by almost 25 per cent for the year, which is about 2.5…

ByUjjwal MaheshwariFebruary 18, 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Investors may remember Rhythm Biosciences (ASX:RHY) for its ColoSTAT test, but it is Genetype that is arguably more exciting. The company now has a substantially larger market awaiting us, and while its commercialisation strategy for ColoSTAT has changed, this strategy has been successful. Wait, has Rhythm received TGA approval? Yes and no - it's a long…

ByNick SundichFebruary 17, 2026

Kelly Partners (ASX:KPG): A Home-Grown Accounting Firm With Strong Growth And Expanding Abroad, So Why Is It Falling?

Kelly Partners (ASX:KPG) has endured a growth record very few ASX companies can rival. It boasts 30.3% revenue CAGR since its IPO and is rapidly expanding overseas. So why then is it down nearly 50% in the last year. Let's look into it. What are the Best ASX Stocks to invest in right now? Check our…

ByNick SundichFebruary 12, 2026

Here are 7 ASX stocks that overinflated during the pandemic and crashed; and where they are now

If you want proof the COVID pandemic was a crazy time, just take a look at a list of ASX stocks that overinflated during that time, and how they subsequently crashed. We have put together one such list, it is not intended to be exhaustive, but we think it covers the main 7 that would…

ByNick SundichFebruary 6, 2026

Does your stock suffer from governance issues? Here are 10 hidden red flags!

No investor would invest in a company with governance issues, but it can be difficult to spot red flags. That is why we decided to write this article - to help investors determine them. Because we have seen these happen so many times over the years in so many companies as red flags that there…

ByNick SundichFebruary 6, 2026

The 50% CGT discount on shares: Here’s how it works, and if it is under threat

The 50% CGT discount on shares is one of the key mechanisms that helps investors keep as much of their cash as they have earned on their investments. We felt that it was time to write a stand-alone article about this in light of the inflation crisis and how it could lead to investors seeking…

ByNick SundichFebruary 5, 2026

the Kick-ass Multipurpose WordPress Theme

Small Caps Stocks

ASX Cannabis Stocks in 2026: Is the risk worth the reward?

Shape Australia Corporation (ASX:SHA): On track for >$1bn revenue this year even in a tough construction market

Sports Entertainment Group (ASX: SEG) Doubles EBITDA and Upgrades Guidance – Is This Small Cap a Buy?

ASX Company Spin: Here are 7 occasions when management tries to sell bad news as good news

Why Investors Are Rotating Into ASX Small Caps- 5 Top Picks for 2026

Rhythm Biosciences (ASX:RHY): Since picking up Genetype, it has never looked back and is more than a one-trick pony!

Kelly Partners (ASX:KPG): A Home-Grown Accounting Firm With Strong Growth And Expanding Abroad, So Why Is It Falling?

Here are 7 ASX stocks that overinflated during the pandemic and crashed; and where they are now

Does your stock suffer from governance issues? Here are 10 hidden red flags!

The 50% CGT discount on shares: Here’s how it works, and if it is under threat

Sectors

Quick Links

Learn

2020, the Golden Year

Investing in the Year of the Rat

Market trouble spots to avoid in 2020

Small Caps Stocks

Sectors

Quick Links

Learn

Add Your Heading Text Here